Naloxone intranasal (Amphastar)

N/A

Report date: 2025/03/12 20:00:47

Base Information

Drug NameNaloxone intranasal (Amphastar)
Drug Alias NameRextovy
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsDrug Overdose
Global Approved IndicationsDrug Overdose
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/03/07
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmphastar Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmphastar Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDrug Overdose
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A